
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 79
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic
Joane Matta, Emmanuel Wiernik, Olivier Robineau, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 1, pp. 19-19
Open Access | Times Cited: 230
Joane Matta, Emmanuel Wiernik, Olivier Robineau, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 1, pp. 19-19
Open Access | Times Cited: 230
COVID-19 Vaccine Hesitancy among French People Living with HIV
Alexandre Vallée, Erwan Fourn, C. Majerholc, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 302-302
Open Access | Times Cited: 99
Alexandre Vallée, Erwan Fourn, C. Majerholc, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 302-302
Open Access | Times Cited: 99
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
Tiffany Charmet, Laura Schaeffer, Rebecca Grant, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100171-100171
Open Access | Times Cited: 82
Tiffany Charmet, Laura Schaeffer, Rebecca Grant, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100171-100171
Open Access | Times Cited: 82
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution
Olivier Robineau, Marie Zins, Mathilde Touvier, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2240985-e2240985
Open Access | Times Cited: 44
Olivier Robineau, Marie Zins, Mathilde Touvier, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2240985-e2240985
Open Access | Times Cited: 44
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
Mohammad Talaei, Sian Faustini, Hayley Holt, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Mohammad Talaei, Sian Faustini, Hayley Holt, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study
Joane Matta, Olivier Robineau, Emmanuel Wiernik, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4261-4271
Closed Access | Times Cited: 29
Joane Matta, Olivier Robineau, Emmanuel Wiernik, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4261-4271
Closed Access | Times Cited: 29
The impact of spatial connectivity on NPIs effectiveness
C Sabbatini, Giulia Pullano, Laura Di Domenico, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
C Sabbatini, Giulia Pullano, Laura Di Domenico, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Using a population-based Kalman estimator to model the COVID-19 epidemic in France: estimating associations between disease transmission and non-pharmaceutical interventions
Annabelle Collin, Boris P. Hejblum, Carole Vignals, et al.
The International Journal of Biostatistics (2023) Vol. 20, Iss. 1, pp. 13-41
Open Access | Times Cited: 15
Annabelle Collin, Boris P. Hejblum, Carole Vignals, et al.
The International Journal of Biostatistics (2023) Vol. 20, Iss. 1, pp. 13-41
Open Access | Times Cited: 15
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
Scandinavian Journal of Public Health (2021) Vol. 50, Iss. 1, pp. 124-135
Open Access | Times Cited: 34
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
Scandinavian Journal of Public Health (2021) Vol. 50, Iss. 1, pp. 124-135
Open Access | Times Cited: 34
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland
Hélène Baysson, Francesco Pennacchio, Ania Wisniak, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e055515-e055515
Open Access | Times Cited: 25
Hélène Baysson, Francesco Pennacchio, Ania Wisniak, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e055515-e055515
Open Access | Times Cited: 25
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020
Ralf Wagner, David Peterhoff, Stephanie Beileke, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 30
Ralf Wagner, David Peterhoff, Stephanie Beileke, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 30
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
Katja Radon, Abhishek Bakuli, Peter Pütz, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Katja Radon, Abhishek Bakuli, Peter Pütz, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 28
The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
Alexandre Speierer, Patricia O. Chocano‐Bedoya, Daniela Anker, et al.
International Journal of Public Health (2022) Vol. 67
Open Access | Times Cited: 20
Alexandre Speierer, Patricia O. Chocano‐Bedoya, Daniela Anker, et al.
International Journal of Public Health (2022) Vol. 67
Open Access | Times Cited: 20
Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: A nested survey in a population-based cohort
Olivier Robineau, Emmanuel Wiernik, Cédric Lemogne, et al.
The Lancet Regional Health - Europe (2022) Vol. 17, pp. 100363-100363
Open Access | Times Cited: 18
Olivier Robineau, Emmanuel Wiernik, Cédric Lemogne, et al.
The Lancet Regional Health - Europe (2022) Vol. 17, pp. 100363-100363
Open Access | Times Cited: 18
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study
Darryl P. Leong, Mark Loeb, Prem Mony, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Darryl P. Leong, Mark Loeb, Prem Mony, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: a prospective population-based study
Baptiste Pignon, Joane Matta, Emmanuel Wiernik, et al.
BMJ Mental Health (2024) Vol. 27, Iss. 1, pp. e300907-e300907
Open Access | Times Cited: 3
Baptiste Pignon, Joane Matta, Emmanuel Wiernik, et al.
BMJ Mental Health (2024) Vol. 27, Iss. 1, pp. e300907-e300907
Open Access | Times Cited: 3
Depressive symptoms and sex differences in the risk of post-COVID-19 persistent symptoms: a prospective population-based cohort study
Joane Matta, Baptiste Pignon, Sofiane Kab, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1053-1061
Open Access | Times Cited: 3
Joane Matta, Baptiste Pignon, Sofiane Kab, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1053-1061
Open Access | Times Cited: 3
Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland
Jan Zejda, Grzegorz Brożek, Małgorzata Kowalska, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 25
Jan Zejda, Grzegorz Brożek, Małgorzata Kowalska, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 25
SARS-CoV-2 Infection During the First and Second Pandemic Waves in Spain: the ENE–COVID Study
Beatriz Pérez‐Gómez, Roberto Pastor‐Barriuso, Nerea Fernández‐de‐Larrea, et al.
American Journal of Public Health (2023) Vol. 113, Iss. 5, pp. 533-544
Open Access | Times Cited: 9
Beatriz Pérez‐Gómez, Roberto Pastor‐Barriuso, Nerea Fernández‐de‐Larrea, et al.
American Journal of Public Health (2023) Vol. 113, Iss. 5, pp. 533-544
Open Access | Times Cited: 9
Trust in sources of information on COVID-19 at the beginning of the pandemic's first wave and incident persistent symptoms in the population-based CONSTANCES cohort: A prospective study
Joane Matta, Emmanuel Wiernik, Olivier Robineau, et al.
Journal of Psychosomatic Research (2023) Vol. 169, pp. 111326-111326
Open Access | Times Cited: 9
Joane Matta, Emmanuel Wiernik, Olivier Robineau, et al.
Journal of Psychosomatic Research (2023) Vol. 169, pp. 111326-111326
Open Access | Times Cited: 9
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2
Valérie Pourcher, Lisa Belin, Cathia Soulié, et al.
AIDS (2022) Vol. 36, Iss. 11, pp. 1545-1552
Open Access | Times Cited: 13
Valérie Pourcher, Lisa Belin, Cathia Soulié, et al.
AIDS (2022) Vol. 36, Iss. 11, pp. 1545-1552
Open Access | Times Cited: 13
Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
Clément Massonnaud, Jonathan Le Roux, Vittoria Colizza, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 479-479
Open Access | Times Cited: 12
Clément Massonnaud, Jonathan Le Roux, Vittoria Colizza, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 479-479
Open Access | Times Cited: 12
ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study
Mélanie Deschasaux, Fabien Szabo de Edelenyi, Nathalie Druesne‐Pecollo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Mélanie Deschasaux, Fabien Szabo de Edelenyi, Nathalie Druesne‐Pecollo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7